from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2846c/efpA

LFCtreatmentdescriptionclass of inhibitor

-1.706

Amikacinug/mL Amikacintranslation

-0.651

Cap5-10ug/mL Capreomycintranslation

-0.653

Rox10-50 ug/mL Roxithromycintranslation

-0.815

SM2-5 ug/mL Streptomycintranslation

-2.135

Tet5-10 ug/mL Tetracyclinetranslation

-1.001

Rif0.2-5ug/mL Rifampicintranscription

-0.338

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.419

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.534

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.854

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.324

Clofazimine10-13 ug/mL Clofaziminerespiration

0.019

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.686

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.025

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.807

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.189

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.336

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.401

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.009

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.558

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.296

KCN5-20 ug/mL Potassium cyaniderespiration

-0.203

NaN30.2-2 mM Sodium aziderespiration

-0.464

Nigericin50 uM Nigericinrespiration

-0.904

TRC10-150 ug/mL Triclosanrespiration

-0.588

TRZ10-25 ug/mL Thioridazinerespiration

-0.842

Valinomycin0.5-10 uM Valinomycinrespiration

-0.085

ZnSO42 mM ZnSO4respiration

0.852

menadione6-10 ug/mL Menadionerespiration

-0.846

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.108

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.056

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.239

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.526

NRP_1Non-replicating persistence stage 1dosRassociated

0.308

Amp0.2mg/mL AmpicillincellWall

-0.061

Cephalexin20-100 ug/mL CephalexincellWall

1.765

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.224

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.663

EMB10-20 ug/mL EthambutolcellWall

2.643

Eta12-40 ug/mL EthionamidecellWall

2.289

INH0.2-0.4 ug/mL IsoniazidcellWall

2.368

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.235

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.105

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.337

BZA0.12 mg/mL BenzamidearomaticAmides

0.183

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.693

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.147

H2O24 mM hydrogen peroxideDNAdamaging

0.184

Levo10 ug/mL LevofloxacinDNAdamaging

0.626

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.209

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.321

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.088

UVUV-irradiationDNAdamaging

0.031

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.224

Antimycin12.5-50 ug/mL Antimycin A?

0.098

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.137

PA_110-50 ug/mL Antitubercular compound PA-1?

0.191

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.477

PA8240.2-2 ug/mL PA-824?

-0.324

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.507

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.350

Verapamil50 uM Verapamil?

0.073

mercaptoethanol2 mM 2-Mercaptoethanol?

0.119

methoxatin10-20 ug/mL Methoxatin?